-
1
-
-
80051634380
-
Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy
-
Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118(6):1452-1462.
-
(2011)
Blood
, vol.118
, Issue.6
, pp. 1452-1462
-
-
Laskin, B.L.1
Goebel, J.2
Davies, S.M.3
Jodele, S.4
-
2
-
-
37449023779
-
The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation
-
Cooke KR, Jannin A, Ho V. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(1 Suppl 1):23-32.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, Issue.1 SUPPL. 1
, pp. 23-32
-
-
Cooke, K.R.1
Jannin, A.2
Ho, V.3
-
3
-
-
79954441390
-
Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy
-
Keir L, Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol. 2011;26(4):523-533.
-
(2011)
Pediatr Nephrol
, vol.26
, Issue.4
, pp. 523-533
-
-
Keir, L.1
Coward, R.J.2
-
4
-
-
79151471122
-
aHUS caused by complement dysregulation: New therapies on the horizon
-
Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26(1):41-57.
-
(2011)
Pediatr Nephrol
, vol.26
, Issue.1
, pp. 41-57
-
-
Waters, A.M.1
Licht, C.2
-
5
-
-
84873650966
-
Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome
-
Tsai HM. Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med. 2013;126(3): 200-209.
-
(2013)
Am J Med
, vol.126
, Issue.3
, pp. 200-209
-
-
Tsai, H.M.1
-
6
-
-
66849128214
-
Renal thrombotic microangiopathy after hematopoietic cell transplant: Role of GVHD in pathogenesis
-
Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4(2):345-353.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, Issue.2
, pp. 345-353
-
-
Changsirikulchai, S.1
Myerson, D.2
Guthrie, K.A.3
McDonald, G.B.4
Alpers, C.E.5
Hingorani, S.R.6
-
7
-
-
38149128260
-
Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study
-
Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008;85(1):22-28.
-
(2008)
Transplantation
, vol.85
, Issue.1
, pp. 22-28
-
-
Siami, K.1
Kojouri, K.2
Swisher, K.K.3
Selby, G.B.4
George, J.N.5
Laszik, Z.G.6
-
8
-
-
45449119331
-
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: Defining a disorder
-
George JN. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant. 2008;41(11):917-918.
-
(2008)
Bone Marrow Transplant
, vol.41
, Issue.11
, pp. 917-918
-
-
George, J.N.1
-
9
-
-
33748689295
-
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
-
Uderzo C, Bonanomi S, Busca A, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006; 82(5):638-644.
-
(2006)
Transplantation
, vol.82
, Issue.5
, pp. 638-644
-
-
Uderzo, C.1
Bonanomi, S.2
Busca, A.3
-
10
-
-
84857595082
-
Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation
-
Jodele S, Bleesing JJ, Mehta PA, et al. Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2012;16(2):E39-E42.
-
(2012)
Pediatr Transplant
, vol.16
, Issue.2
-
-
Jodele, S.1
Bleesing, J.J.2
Mehta, P.A.3
-
11
-
-
33745872977
-
Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment
-
Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17(7):1995-2005.
-
(2006)
J Am Soc Nephrol
, vol.17
, Issue.7
, pp. 1995-2005
-
-
Hingorani, S.1
-
12
-
-
34247401041
-
Significant increase in end-stage renal disease after hematopoietic stem cell transplantation
-
Cohen EP, Drobyski WR, Moulder JE. Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39(9):571-572.
-
(2007)
Bone Marrow Transplant
, vol.39
, Issue.9
, pp. 571-572
-
-
Cohen, E.P.1
Drobyski, W.R.2
Moulder, J.E.3
-
13
-
-
84874610717
-
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
-
European Working Party on Complement Genetics in Renal Diseases
-
Bresin E, Rurali E, Caprioli J, et al European Working Party on Complement Genetics in Renal Diseases. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol. 2013;24(3): 475-486.
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.3
, pp. 475-486
-
-
Bresin, E.1
Rurali, E.2
Caprioli, J.3
-
14
-
-
84858633062
-
Eculizumab and refractory membranoproliferative glomerulonephritis
-
Radhakrishnan S, Lunn A, Kirschfink M, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med. 2012;366(12): 1165-1166.
-
(2012)
N Engl J Med
, vol.366
, Issue.12
, pp. 1165-1166
-
-
Radhakrishnan, S.1
Lunn, A.2
Kirschfink, M.3
-
15
-
-
38949155911
-
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
-
Józsi M, Licht C, Strobel S, et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood. 2008;111(3):1512-1514.
-
(2008)
Blood
, vol.111
, Issue.3
, pp. 1512-1514
-
-
Józsi, M.1
Licht, C.2
Strobel, S.3
-
16
-
-
77957581739
-
The autoimmune disease DEAP-hemolytic uremic syndrome
-
Skerka C, Zipfel PF, Müller D, Micklisch S, Riedl M, Zimmerhackl LB, Hofer J. The autoimmune disease DEAP-hemolytic uremic syndrome. Semin Thromb Hemost. 2010;36(6):625-632.
-
(2010)
Semin Thromb Hemost
, vol.36
, Issue.6
, pp. 625-632
-
-
Skerka, C.1
Zipfel, P.F.2
Müller, D.3
Micklisch, S.4
Riedl, M.5
Zimmerhackl, L.B.6
Hofer, J.7
-
17
-
-
78349238830
-
Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation
-
Cho BS, Yahng SA, Lee SE, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90(8):918-926.
-
(2010)
Transplantation
, vol.90
, Issue.8
, pp. 918-926
-
-
Cho, B.S.1
Yahng, S.A.2
Lee, S.E.3
-
18
-
-
22344434696
-
Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation
-
Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(8):571-575.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, Issue.8
, pp. 571-575
-
-
Ho, V.T.1
Cutler, C.2
Carter, S.3
-
19
-
-
84874946877
-
Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
-
Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, Davies SM. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Transfusion. 2013;53(3):661-667.
-
(2013)
Transfusion
, vol.53
, Issue.3
, pp. 661-667
-
-
Jodele, S.1
Laskin, B.L.2
Goebel, J.3
Khoury, J.C.4
Pinkard, S.L.5
Carey, P.M.6
Davies, S.M.7
-
20
-
-
79955893687
-
Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT
-
Laskin BL, Goebel J, Davies SM, et al. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. Bone Marrow Transplant. 2011;46(5):682-689.
-
(2011)
Bone Marrow Transplant
, vol.46
, Issue.5
, pp. 682-689
-
-
Laskin, B.L.1
Goebel, J.2
Davies, S.M.3
-
21
-
-
84872258720
-
Wellcome Trust Case Control Consortium 2. Insights into the genetic architecture of early stage age-related macular degeneration: A genome-wide association study meta-analysis
-
Holliday EG, Smith AV, Cornes BK, et al; Wellcome Trust Case Control Consortium 2. Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS ONE. 2013;8(1):e53830.
-
(2013)
PLoS ONE
, vol.8
, Issue.1
-
-
Holliday, E.G.1
Smith, A.V.2
Cornes, B.K.3
-
22
-
-
75649133611
-
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
-
Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010;115(2): 379-387.
-
(2010)
Blood
, vol.115
, Issue.2
, pp. 379-387
-
-
Moore, I.1
Strain, L.2
Pappworth, I.3
-
23
-
-
77956231486
-
DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome
-
European DEAP-HUS Study Group
-
Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C; European DEAP-HUS Study Group. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol. 2010;25(10): 2009-2019.
-
(2010)
Pediatr Nephrol
, vol.25
, Issue.10
, pp. 2009-2019
-
-
Zipfel, P.F.1
Mache, C.2
Müller, D.3
Licht, C.4
Wigger, M.5
Skerka, C.6
-
24
-
-
76949087440
-
Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
-
Abarrategui-Garrido C, Martínez-Barricarte R, López- Trascasa M, de Córdoba SR, Sánchez- Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. 2009;114(19):4261-4271.
-
(2009)
Blood
, vol.114
, Issue.19
, pp. 4261-4271
-
-
Abarrategui-Garrido, C.1
Martínez-Barricarte, R.2
López- Trascasa, M.3
De Córdoba, S.R.4
Sánchez- Corral, P.5
-
25
-
-
84864925248
-
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
-
Foltyn Zadura A, Zipfel PF, Bokarewa MI, et al. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther. 2012;14(4):R185.
-
(2012)
Arthritis Res Ther
, vol.14
, Issue.4
-
-
Foltyn Zadura, A.1
Zipfel, P.F.2
Bokarewa, M.I.3
-
26
-
-
70349441306
-
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
-
Heinen S, Hartmann A, Lauer N, et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood. 2009;114(12):2439-2447.
-
(2009)
Blood
, vol.114
, Issue.12
, pp. 2439-2447
-
-
Heinen, S.1
Hartmann, A.2
Lauer, N.3
-
27
-
-
80052272216
-
Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome
-
Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome. Kidney Int. 2011;80(4):397-404.
-
(2011)
Kidney Int
, vol.80
, Issue.4
, pp. 397-404
-
-
Strobel, S.1
Abarrategui-Garrido, C.2
Fariza-Requejo, E.3
Seeberger, H.4
Sánchez-Corral, P.5
Józsi, M.6
-
28
-
-
84878657666
-
The use of eculizumab in renal transplantation
-
Barnett AN, Asgari E, Chowdhury P, Sacks SH, Dorling A, Mamode N. The use of eculizumab in renal transplantation. Clin Transplant. 2013;27(3): E216-E229.
-
(2013)
Clin Transplant
, vol.27
, Issue.3
-
-
Barnett, A.N.1
Asgari, E.2
Chowdhury, P.3
Sacks, S.H.4
Dorling, A.5
Mamode, N.6
-
29
-
-
84873288473
-
Eculizumab for the treatment of preeclampsia/HELLP syndrome
-
Burwick RM, Feinberg BB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta. 2013;34(2):201-203.
-
(2013)
Placenta
, vol.34
, Issue.2
, pp. 201-203
-
-
Burwick, R.M.1
Feinberg, B.B.2
-
30
-
-
84875803456
-
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
-
Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V, Coppo P, Fischer AM, Helley D, Socié G. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol. 2013;161(2):279-280.
-
(2013)
Br J Haematol
, vol.161
, Issue.2
, pp. 279-280
-
-
Peffault De Latour, R.1
Xhaard, A.2
Fremeaux-Bacchi, V.3
Coppo, P.4
Fischer, A.M.5
Helley, D.6
Socié, G.7
|